Cargando…
Synthetic Biology Technologies And Genetically Engineering Strategies For Enhanced Cell Therapeutics
Stem cell therapy mainly uses natural stem cells for transplantation, and the use of genetic engineering to optimize stem cell products is a very important process. This article reviews successful gene modification methods in the field of immune cell therapy and summarizes some attempts at stem cell...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9514184/ https://www.ncbi.nlm.nih.gov/pubmed/36166137 http://dx.doi.org/10.1007/s12015-022-10454-5 |
_version_ | 1784798222900789248 |
---|---|
author | Li, Siyu Tang, Hao Li, Cheng Ma, Jiajia Ali, Maqsood Dong, Qi Wu, Jiajia Hui, Yang Sun, Chongran |
author_facet | Li, Siyu Tang, Hao Li, Cheng Ma, Jiajia Ali, Maqsood Dong, Qi Wu, Jiajia Hui, Yang Sun, Chongran |
author_sort | Li, Siyu |
collection | PubMed |
description | Stem cell therapy mainly uses natural stem cells for transplantation, and the use of genetic engineering to optimize stem cell products is a very important process. This article reviews successful gene modification methods in the field of immune cell therapy and summarizes some attempts at stem cell gene editing in current research. Cell bridging is an innovative cutting-edge strategy that includes the specific recognition and signal transduction of artificial receptors. The “off-the-shelf” cell strategies mainly introduce the advantages of allogeneic cell therapy and how to overcome issues such as immunogenicity. Gene regulatory systems allow us to manipulate cells with small molecules to control cellular phenotypes. In addition, we also summarize some important genes that can provide a reference for cell genetic engineering. In conclusion, we summarize a variety of technical strategies for gene editing cells to provide useful ideas and experiences for future stem cell therapy research. GRAPHICAL ABSTRACT: [Image: see text] |
format | Online Article Text |
id | pubmed-9514184 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Springer US |
record_format | MEDLINE/PubMed |
spelling | pubmed-95141842022-09-28 Synthetic Biology Technologies And Genetically Engineering Strategies For Enhanced Cell Therapeutics Li, Siyu Tang, Hao Li, Cheng Ma, Jiajia Ali, Maqsood Dong, Qi Wu, Jiajia Hui, Yang Sun, Chongran Stem Cell Rev Rep Article Stem cell therapy mainly uses natural stem cells for transplantation, and the use of genetic engineering to optimize stem cell products is a very important process. This article reviews successful gene modification methods in the field of immune cell therapy and summarizes some attempts at stem cell gene editing in current research. Cell bridging is an innovative cutting-edge strategy that includes the specific recognition and signal transduction of artificial receptors. The “off-the-shelf” cell strategies mainly introduce the advantages of allogeneic cell therapy and how to overcome issues such as immunogenicity. Gene regulatory systems allow us to manipulate cells with small molecules to control cellular phenotypes. In addition, we also summarize some important genes that can provide a reference for cell genetic engineering. In conclusion, we summarize a variety of technical strategies for gene editing cells to provide useful ideas and experiences for future stem cell therapy research. GRAPHICAL ABSTRACT: [Image: see text] Springer US 2022-09-27 2023 /pmc/articles/PMC9514184/ /pubmed/36166137 http://dx.doi.org/10.1007/s12015-022-10454-5 Text en © The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature 2022, Springer Nature or its licensor holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law. This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic. |
spellingShingle | Article Li, Siyu Tang, Hao Li, Cheng Ma, Jiajia Ali, Maqsood Dong, Qi Wu, Jiajia Hui, Yang Sun, Chongran Synthetic Biology Technologies And Genetically Engineering Strategies For Enhanced Cell Therapeutics |
title | Synthetic Biology Technologies And Genetically Engineering Strategies For Enhanced Cell Therapeutics |
title_full | Synthetic Biology Technologies And Genetically Engineering Strategies For Enhanced Cell Therapeutics |
title_fullStr | Synthetic Biology Technologies And Genetically Engineering Strategies For Enhanced Cell Therapeutics |
title_full_unstemmed | Synthetic Biology Technologies And Genetically Engineering Strategies For Enhanced Cell Therapeutics |
title_short | Synthetic Biology Technologies And Genetically Engineering Strategies For Enhanced Cell Therapeutics |
title_sort | synthetic biology technologies and genetically engineering strategies for enhanced cell therapeutics |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9514184/ https://www.ncbi.nlm.nih.gov/pubmed/36166137 http://dx.doi.org/10.1007/s12015-022-10454-5 |
work_keys_str_mv | AT lisiyu syntheticbiologytechnologiesandgeneticallyengineeringstrategiesforenhancedcelltherapeutics AT tanghao syntheticbiologytechnologiesandgeneticallyengineeringstrategiesforenhancedcelltherapeutics AT licheng syntheticbiologytechnologiesandgeneticallyengineeringstrategiesforenhancedcelltherapeutics AT majiajia syntheticbiologytechnologiesandgeneticallyengineeringstrategiesforenhancedcelltherapeutics AT alimaqsood syntheticbiologytechnologiesandgeneticallyengineeringstrategiesforenhancedcelltherapeutics AT dongqi syntheticbiologytechnologiesandgeneticallyengineeringstrategiesforenhancedcelltherapeutics AT wujiajia syntheticbiologytechnologiesandgeneticallyengineeringstrategiesforenhancedcelltherapeutics AT huiyang syntheticbiologytechnologiesandgeneticallyengineeringstrategiesforenhancedcelltherapeutics AT sunchongran syntheticbiologytechnologiesandgeneticallyengineeringstrategiesforenhancedcelltherapeutics |